Rossotti et al. [134] showed that the tetanus-neutralising capacity of nanobodies from llamas was drastically improved following their fusion to a second nanobody specific to the complement receptor CD11b/CD18 (Mac-1), enabling the mice to survive a 10-fold more lethal dose of the tetanus toxin [134]. The gene discussed is ITGB2; the disease is tetanus.